Detalhe da pesquisa
1.
Pathogenic Th1 responses in CHIKV-induced inflammation and their modulation upon Plasmodium parasites co-infection.
Immunol Rev
; 294(1): 80-91, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31773780
2.
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection.
J Med Virol
; 95(5): e28774, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212320
3.
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
J Med Virol
; 95(1): e28258, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305052
4.
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
J Clin Immunol
; 42(2): 214-229, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716845
5.
Correction to: Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
J Clin Immunol
; 42(2): 230-231, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837161
6.
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya.
EMBO Mol Med
; 16(3): 641-663, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332201
7.
Monkeypox: disease epidemiology, host immunity and clinical interventions.
Nat Rev Immunol
; 22(10): 597-613, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064780
8.
Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells.
Life Sci Alliance
; 5(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039441
9.
Decreased memory B cell frequencies in COVID-19 delta variant vaccine breakthrough infection.
EMBO Mol Med
; 14(3): e15227, 2022 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34994081
10.
Insights into Antibody-Mediated Alphavirus Immunity and Vaccine Development Landscape.
Microorganisms
; 9(5)2021 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-33922370
11.
Asymptomatic COVID-19: disease tolerance with efficient anti-viral immunity against SARS-CoV-2.
EMBO Mol Med
; 13(6): e14045, 2021 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33961735
12.
Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.
Clin Transl Immunology
; 10(2): e1241, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33628442
13.
Data-Driven Analysis of COVID-19 Reveals Persistent Immune Abnormalities in Convalescent Severe Individuals.
Front Immunol
; 12: 710217, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34867943
14.
Type I interferon shapes the quantity and quality of the anti-Zika virus antibody response.
Clin Transl Immunology
; 9(4): e1126, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-32346479
15.
Longitudinal [18F]FB-IL-2 PET Imaging to Assess the Immunopathogenicity of O'nyong-nyong Virus Infection.
Front Immunol
; 11: 894, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32477364
16.
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.
Nat Commun
; 11(1): 2806, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32483236
17.
Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity.
EBioMedicine
; 58: 102911, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711254
18.
Viperin controls chikungunya virus-specific pathogenic T cell IFNγ Th1 stimulation in mice.
Life Sci Alliance
; 2(1)2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665948
19.
Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant.
Lancet Reg Health West Pac
; 33: 100732, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125085
20.
Resistance of SARS-CoV-2 Delta variant to neutralization by BNT162b2-elicited antibodies in Asians.
Lancet Reg Health West Pac
; 15: 100276, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34568853